ArticleGenome biology2026
Data-driven AI system for learning how to run transcript assemblers.
Article in Genome biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
3 authors.
Funding
Abstract
We introduce AutoTuneX, a data-driven, AI system designed to automatically predict optimal parameters for transcript assemblers - tools for reconstructing transcripts from the reads in a given RNA-seq sample. AutoTuneX is built by learning parameter knowledge from existing RNA-seq samples and transferring this knowledge to unseen samples. On 1588 human RNA-seq samples tested with two transcript assemblers, AutoTuneX predicts parameters that resulted in 98% of samples achieving more accurate transcript assembly compared to using default parameters, with some samples experiencing up to a 600% improvement in AUC. AutoTuneX offers a new strategy for automatically optimizing use of sequence analysis tools.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.